Author

J. M. Sepulveda-Sanchez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1

Frequent Co-Authors

A. Hernandez-Lain· 3 shared A. Perez-Nunez· 3 shared B. Herranz· 3 shared B. Segura-Collar· 3 shared P. Sanchez-Gomez· 3 shared R. Gargini· 3 shared D. Garcia-Perez· 2 shared A. Ayuso-Sacido· 1 shared

Activity by Year

2019-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

A. Hernandez-Lain

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 21, 2020

The genetic status of IDH1/2 and EGFR dictates the vascular landscape and the progression of gliomas

B. Segura-Collar, M. Garranzo-Asensio, B. Herranz…·P. Sanchez-Gomez

This study investigates how IDH1/2 and EGFR genetic mutations influence vascular characteristics and progression in gliomas, identifying distinct vascular phenotypes and therapeutic vulnerabilities.

DOI 10.1101/2020.09.21.306134

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivJul 17, 2020

Immune profiling of gliomas reveals a connection with Tau function and the tumor vasculature.

P. Sanchez-Gomez, J. M. Sepulveda-Sanchez, T. Cejalvo…·M. C. Martin-Soberon

The paper profiles immune cells in gliomas, identifying two immune profiles in IDH1/2 wild-type tumors and linking immune content to vascular alterations and Tau expression.

DOI 10.3390/cancers12113230

humanflow cytometry

𝕏 PostBluesky

Cancer BiologybioRxivOct 3, 2019

IDH-Tau-EGFR triad defines the neovascular landscape of diffuse gliomas by controlling mesenchymal differentiation

R. Gargini, B. Segura-Collar, V. Garcia-Escudero…·A. Perez-Nunez

This study identifies the IDH-Tau-EGFR triad as a key factor in defining the neovascular landscape of diffuse gliomas by regulating mesenchymal differentiation and vascular microenvironment.

DOI 10.1126/scitranslmed.aax1501

humanbulk RNA-seq

𝕏 PostBluesky